Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Oncology | Nephrology | Family Medicine
Bladder Cancer Clinical Trials
A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 4 Last
Alabama
University of Alabama Hematology Oncology Clinic at Medical West
Updated
A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma
Arizona
Mayo Clinic Hospital
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
BCG Oncology
Patients are needed to participate in a clinical research study of TMX-101 to evaluate Carcinoma in Situ or Non Muscle Invasive Bladder Cancer
Mayo Clinic Arizona
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
California
City of Hope
Updated
A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma
City of Hope Medical Center
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
USC/Norris Comprehensive Cancer Center
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
VA Palo Alto Health Care System
A clinical trial seeking patients for a research study for the treatment of Bladder Cancer
Genesis Research
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
View More »
Stanford University School of Medicine
A clinical trial seeking patients for a research study of Pazopanib (GW786034) and Paclitaxel
Stanford University Hospital
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
Colorado
The Urology Center of Colorado
Phase 2, randomized, open label, parallel ARM study to evaluate the safety and efficacy of rAd-IFN/Syn 3 following intravesical administration in subjects with high grade, BCG refractory or relapsed non-muscle invasive bladder cancer.
The Urology Center of Colorado
Phase II Pilot Study with TMX-101 in Patients with Carcinoma in Situ (CIS) Bladder Cancer
The Urology Center of Colorado
Phase II, open-label study evaluating DN24-02 as adjuvant therapy in subjects with high risk HER2+ urothelial carcinoma.
View More »
University of Colorado, Anschutz Cancer Pavilion
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
The Urology Center of Colorado
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
The Urology Center of Colorado
Patients are needed to participate in a clinical research study of TMX-101 to evaluate Carcinoma in Situ or Non Muscle Invasive Bladder Cancer
Connecticut
Neag Comprehensive Cancer Center/University of Connecticut Health Center
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
Florida
Urological Research Network
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
University of Miami Miller School of Medicine
A Phase 1/Phase 2 clinical study for patients with Urothelial Carcinoma
University of Miami Cancer Center
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
MD Anderson Cancer Center Orlando
A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer
M.D. Anderson Cancer Center Orlando
Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis
View More »
Martin Health System
A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer
Martin Health System
Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis
H. Lee Moffitt Cancer Center and Research Institute
A clinical trial seeking patients for a research study for the treatment of Bladder Cancer
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis
Georgia
Emory University Department of Urology
Updated
A clinical research study of Monopolar electrocautery loop in Transurethral resection of bladder tumors and PK Button Vaporization Electrode in transurethral resection of bladder tumors for the treatment of Bladder Cancer
The Emory Clinic
Hexvix Cystoscopy for Detection of Bladder Cancer
Emory University
Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis
Illinois
University of Chicago Medical Center
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
The University of Chicago
Patients are needed to participate in a clinical research study evaluating Neo-Urinary Conduit for the treatment of Bladder Cancer
Robert Lurie Comprehensive Cancer Center of Northwestern University
Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis
Indiana
IU Health Goshen Hospital
Updated
A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma
Indiana University Simon Cancer Center
A clinical trial to evaluate treatments using Amrubicin for patients with Bladder Cancer
Indiana University Melvin and Bren Simon Cancer Center
A clinical trial to evaluate treatments using Dovitinib for patients with Bladder Cancer
IU Health Central Indiana Cancer Centers
Updated
A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma
Indiana University Melvin & Bren Simon Cancer Center
Updated
A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma
View More »
Indiana University
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
IU Health at Ball Memorial Hospital
Updated
A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma
Iowa
University of Iowa Hospitals and Clinics
Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis
Kansas
University of Kansas Cancer Center
Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis
Kansas City Urology Care
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
University of Kansas Cancer Center
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
Maryland
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
Johns Hopkins Hospital
Patients are needed to participate in a clinical research study evaluating DN24-02 and Standard of Care for the treatment of Urothelial Carcinoma
The Johns Hopkins Medical Institutions
Patients are needed to participate in a clinical research study evaluating Neo-Urinary Conduit for the treatment of Bladder Cancer
National Cancer Institute
Patients are needed to participate in a clinical research study evaluating Lenalidomide for the treatment of Metastatic Urothelial Carcinoma
Massachusetts
Dana Farber Cancer Institute
A clinical trial to evaluate treatments using MGA271 for patients
First 1 2 3 4 Last
